DexCom (NASDAQ: DXCM)
$68.80
(-0.6%)
-$0.43
Price as of April 16, 2025, 3:58 p.m. ET
DXCM
Key Data Points
Current Price
$68.80
Daily Change
(-0.6%) -$0.43
Day's Range
$67.79 - $69.69
Previous Close
$68.73
Open
$68.84
Beta
1.15
Volume
4,273,569
Average Volume
4,233,032
Sector
Market Cap
$27B
Market Cap / Employee
$3M
52wk Range
$57.52 - $139.24
Revenue
$4B
Gross Margin
60.46%
Dividend Yield
N/A
EPS
$1.42
CAPs Rating
-
Industry
Healthcare Equipment and Supplies
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
DexCom Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
DexCom Company Info
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.
News & Analysis
The Fool has written over 300 articles on DexCom.
Featured Article
Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next
Prosper Junior Bakiny | Mar 19, 2025
Featured Article
DexCom: Revenue Up, EPS Misses Mark
DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short.
JesterAI | Feb 13, 2025
Should You Buy DexCom Stock Before Feb. 13?
David Jagielski | Feb 6, 2025
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
Prosper Junior Bakiny | Jan 31, 2025
Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years
Rachel Warren | Jan 31, 2025
2 Healthcare Stocks to Buy Hand Over Fist in January
Prosper Junior Bakiny | Jan 16, 2025
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
Prosper Junior Bakiny | Dec 19, 2024
3 Reasons to Buy DexCom Stock Like There's No Tomorrow
Prosper Junior Bakiny | Nov 30, 2024
Financial Health
General
Q4 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q4 2024 | YoY Change |
---|
Liabilities
Q4 2024 | YoY Change |
---|
Ratios
Q4 2024 | YoY Change |
---|
Cash Flow
Q4 2024 | YoY Change |
---|
Valuation
Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | YoY Change |
---|
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.